Position in GSK
as of Jun 30, 2026
· filed Jul 29, 2026
Position Value
$295,439
-$9,485 QoQ
Shares Held
5,636
+2.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.09%
of 13F equity value
Holder Rank
#606
of 1,033 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in GSK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Cordatus Wealth Management LLC holds $25,634,141 across 8 Drug Manufacturers - General names. GSK ranks #8 (1.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
32,020 | $8,132,119 | |
| 2 | LLY |
ELI LILLY & Co
|
4,307 | $5,165,945 | |
| 3 | ABBV |
AbbVie Inc.
|
16,405 | $4,128,154 | |
| 4 | MRK |
Merck & Co., Inc.
|
29,906 | $3,842,921 | |
| 5 | AMGN |
Amgen Inc
|
8,245 | $2,985,679 | |
| 6 | NVS |
Novartis AG
|
4,593 | $719,814 | |
| 7 | AZN |
Astrazeneca PLC
|
1,920 | $364,070 | |
| 8 | GSK |
GSK plc
This page
|
5,636 | $295,439 |
All Filings in GSK
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $295,439 | 5,636 | Shares | Sole | 2026-07-29 | |
| 2026-03-31 | $304,924 | 5,525 | Shares | Sole | 2026-04-29 | |
| No filing history on record for this holder in this stock. | ||||||